Navigation Links
Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone
Date:12/27/2008

SAN DIMAS, Calif., Dec. 27 /PRNewswire/ -- According to the latest science, resveratrol pill users are best advised to consume modest doses of resveratrol plus an array of antioxidant molecules as typically provided in 3 to 5 glasses of aged, red wine, rather than resveratrol alone.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080603/LATU039 )

The most recent study shows mega-dose resveratrol alone fails to prolong the life of laboratory mice. In fact, mega-doses shortened the life of animals compared to a standard calorie diet with no resveratrol. [Cell Metabolism. 2008 Aug; 8:157-68]

"While resveratrol (rez-vair-ah-trol), an antioxidant molecule concentrated in red wine (about 1 milligram per glass), is touted for its health properties, partially explaining the French Paradox (why French wine drinkers have cardiac mortality rates 30% lower than North Americans despite their high-calorie, high-fat diets), it is not the sole molecule responsible for longevity," says Bill Sardi, spokesperson for Longevinex(R), a leading brand of resveratrol dietary supplement.

"The total array of red wine molecules found in the best red wine, about 60 milligrams per 5-ounce glass, or 180-300 milligrams in 3 to 5 glasses, is the suggested healthy dosage range," says Sardi.

Consistently, studies show modest doses of red wine lower mortality rates over abstention or over-consumption. [American Journal Epidemiology 1986 Sep; 124(3):481-9] Red wine pills offer the advantage of no alcohol, no calories or sulfite preservatives.

Cause of shortened lifespan

The negative effect upon lifespan with mega-dose resveratrol may emanate from over-inhibition of tumor necrosis factor (TNF), an inflammatory factor. Excessive TNF leads to inflammation, while too little impairs the immune sys
'/>"/>

SOURCE Longevinex
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Resveratrol Longevity Science Makes Dramatic U-Turn, But Resveratrol Supplements Remain Unchanged
2. Consumer Group Urges Gov. Schwarzenegger to Sign Stem Cell Bill Into Law
3. Agriculture Department Warns Consumers of Tainted Raw Milk Sold by Lebanon County Dairy
4. Florastor(R) Receives ConsumerLab.com Certification
5. Survey Finds At-Risk Consumers Interested in OTC Statin
6. Dog Law Officers Crackdown on Unsatisfactory Kennels Protecting Animals, Consumers
7. Agriculture Department Warns Consumers of Tainted Raw Milk Sold by Chester County Dairy
8. Consumer Advocates Support Patent Office on Stem Cell Patent Rejection
9. CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease
10. Trius Doses First Patient in Antibacterial Phase 2 Trial
11. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... new analysis of Centers for Medicare and Medicaid Services, ... 81 percent of seniors chose lower-cost preferred pharmacy plans ... pharmacies. The findings were released by Drug Channels ... foundation of Medicare Part D," said Pharmaceutical Care Management ...
(Date:1/23/2015)... NEW YORK , Jan. 23, 2015 /PRNewswire/-- Harwood Feffer ... the board of directors of Advaxis, Inc. ("Advaxis" or ... the board has breached its fiduciary duties to shareholders. ... published on an investing website reporting that Advaxis had ...
(Date:1/23/2015)... Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), announced ... trial of Lixte,s lead compound, LB‑100, is being conducted, has ... John S. Kovach , M.D., the founder and President of ... completed at a single site. Accrual of patients, however, was ...
Breaking Medicine Technology:New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
... Oct. 7 DiFUSION Technologies is a medical ... of its proprietary CleanFUZE™ antimicrobial technology for orthopedic ... Interbody products for spinal surgery. "Post-operative ... the further proliferation of drug resistant bacteria, preventing ...
... Community Pharmacists Association (NCPA) has announced its current ... and Trade Exposition scheduled for October 23-27, 2010 ... (Logo:   http://www.newscom.com/cgi-bin/prnh/20100106/DC33253LOGO ) (Logo:   ... Exposition is the most powerful and productive trade ...
Cached Medicine Technology:DiFUSION Technologies Completes Successful Antimicrobial Implant Animal Trial 2DiFUSION Technologies Completes Successful Antimicrobial Implant Animal Trial 3NCPA Announces Exhibit Hall Activities for 2010 NCPA Annual Convention and Trade Exposition 2
(Date:1/22/2015)... 23, 2015 The U.S. Pharmacopeial Convention ... Director of Clinical Pharmacy Services at North Carolina State’s ... of the 2015 Beal Award for Distinguished Volunteer Service—the ... relied on the contributions of volunteer experts to direct ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Woodloch Pines, an ... has been selected by TripAdvisor as the number one best ... 6th best in the world for their annual Travelers’ Choice ... travel community . The website is home to millions of ...
(Date:1/22/2015)... Houston, TX (PRWEB) January 22, 2015 The ... Pro Bodybuilder Ben Pakulski to increase lean muscle by up ... This has caught the attention of HealthyandFitZone.com’s Stan Stevenson, prompting ... shows that it is a step-by-step, scientific diet formula that ...
(Date:1/22/2015)... York, New York (PRWEB) January 22, 2015 ... http://www.vaginalmeshlawsuit2015.com/ ) in the U.S. District Court, Southern District of ... C.R. Bard, Inc. in that proceeding’s first bellwether trial. In ... request for a new trial after finding that C.R. Bard ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Autocarinsurancebest.com has released ... purchasing a commercial auto insurance policy . , Auto ... their vehicles. It is no longer necessary to call an ... are now available online on a single website: http://autocarinsurancebest.com/ ...
Breaking Medicine News(10 mins):Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 2Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 3Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 4Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2
... Mich., Dec. 3 Stryker (NYSE: SYK ),announced ... cash,dividend of forty cents per share, an increase of 21% ... dividend is payable January 30,2009 to shareholders of record at ... "Our continued growth in 2008 ...
... mental health 15 years later , , WEDNESDAY, Dec. 3 ... a social development program in elementary school had improved ... as young adults, a new study finds. , Crime, ... problems are among the challenges faced by many children ...
... and LISLE, Ill., Dec. 3 Allied,National of ... Illinois,entered into an agreement to deliver cost savings ... quality, savings and experience for,surgery through Healthplace America,s ... Healthplace Benefit(TM) is the first -- and only ...
... of blood clots, researchers at the University of Oklahoma Health ... the blood, but seems to play a primary role in ... research appeared in recent issues of the journal Blood ... , A research group at OU led by Patrick McKee ...
... Need for Labor Law Reform , , ... Center have reached a tentative agreement with hospital management for a ... for workers, and an average wage increase of 33 percent over ... the contract would cap more than a year of bargaining that ...
... A research team led by the La Jolla Institute ... illuminated the important role of natural killer (NK) T ... understood white blood cells are central to clearing the ... arthritis associated with Lyme disease. , "Our findings are ...
Cached Medicine News:Health News:School-Based Program Can Change Kids' Lives 2Health News:Allied National Partners With Healthplace America to Provide Significant Healthcare Savings 2Health News:Allied National Partners With Healthplace America to Provide Significant Healthcare Savings 3Health News:Researchers discover new enzyme in cancer growth 2Health News:Healthcare Workers Reach Tentative Agreement With Enloe Medical Center 2Health News:Researchers identify cell group key to Lyme disease arthritis 2Health News:Researchers identify cell group key to Lyme disease arthritis 3
CCR Medical conventional laryngoscopes....
CCR Medical conventional laryngoscopes....
... LMA™ Airway., ,Launched in 1988, this ... is now standard practice in general anesthesia. ... the LMA Classic™ is a safe hands ... ,The LMA Classic™ can be used for ...
... Wire-Reinforced LMA ™ Airway., ,The ... tube which allows it to be ... while maintaining a good seal. This ... and dental surgery, or other procedures ...
Medicine Products: